EWTX Edgewise Corp: Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan

Simbol resmi perusahaan Edgewise Therapeutics, Inc. (EWTX)

Liquidity shortages and the depletion of reserves due to R&D expenditures are creating financial pressure on Edgewise Therapeutics (EWTX). The GURU.Markets platform reports quarterly earnings per share (EPS) growth, where 2608.80 serves as the current metric. Partnerships with medical centers treating skeletal pathologies and the company's status as an innovator in developing small molecules for muscle protection provide positive momentum.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Edgewise Therapeutics, Inc. (EWTX): kanggo periode 04.07.2022 - 16.11.2026

Rincian analitis perusahaan Edgewise Therapeutics

Analisis fundamental perusahaan:edgewisetx.com, EWTX
Produk asil prodhuksi Edgewise Corp

Investors often face the challenge of the market misperceiving a company's interim results. The reduction of capital expenditures through the outsourcing of clinical trials and manufacturing at Edgewise Therapeutics (EWTX) stabilizes the operating base. This indicator measures the rate of change in earnings per share, eliminating information gaps between reports. By analyzing the quarterly EPS trend, one can identify the risk of overpaying during sharp peaks, which allows for the precise calibration of the entry point into the asset.

Analisis perusahaan pesaing

JAZZ (Jazz Pharmaceuticals PLC) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cytokinetics Corp (CYTK) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan PTC Therapeutics, Inc.|SRRK: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Centessa Corp (CNTA)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan DYN (Dyne Therapeutics Inc)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Rapport Pharma RAPP|Alumis Pharma - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|ZVRA - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Contineum Therapeutics, Inc.|LRMR: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Capricor Therapeutics CAPR|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan TRDA|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Channel PTHS|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MediciNova Inc. (MNOV)|SER - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan BTAI (BioXcel Therapeutics Inc)|ProMIS Neurosciences (PMN) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Apimeds Pharmaceuticals, Inc. - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan AEON Biopharma, Inc.|NLSP (NLS Pharma) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan BNOX|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan FSD Pharma|Wutah bathi EPS kuartalan Reata